Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plato BioPharma
Westminster, Colorado, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Plato BioPharma provides integrated preclinical in vivo pharmacology services and custom study design for the evaluation of therapeutic candidates, including pharmacokinetics, biomarker profiling, and proof-of-concept efficacy in disease models. The company contributed to key work characterizing tenapanor, a sodium/hydrogen exchanger 3 inhibitor[1][2].
- Therapeutic areas
- NephrologyCardiovascularEndocrinologyGastroenterologyPulmonology
- Modalities
- Small moleculeBiologicProteinPeptides
- Industry
- Drug Discovery Services
02
Partnerships
Ardelyx (collaborative research)AstraZeneca (tenapanor project, indirect)
Beyond the preview
Go deeper on Plato BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Plato BioPharma.